Patent Assignment
Reel/Frame 070262/0648
Assignment of Assignor's Interest
Recorded: 2025-02-19
Pages: 8
Assignor
SPIRFIRE PHARMA, INC.
Executed: 2019-07-12
Assignee
MEDERIS DIABETES LLC
725 LYNWOOD DR., ENCINITAS, CALIFORNIA, 92024
Covered Properties
(3)
Peptide Pharmaceuticals for Insulin Resistance
Application:
16/747,759 →
Publication:
US 2020/0277351
Peptide Pharmaceuticals for Insulin Resistance
Application:
18/943,440 →
Publication:
US 2025/0136656
Peptide Pharmaceuticals for Insulin Resistance
Application:
18/988,066 →
Publication:
US 2025/0313604
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 19, 2025
From: N, JOHN J.
To: SPITFIRE PHARMA, INC.
Reel/Frame 070262/0605 →
Affidavit of Address Change
Feb 19, 2025
From: MEDERIS DIABETES, LLC
To: MEDERIS DIABETES LLC
Reel/Frame 070266/0875 →
Security Interest
May 14, 2025
From: ALTIMMUNE, INC.; SPITFIRE PHARMA, LLC
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 071108/0692 →